UB-VV410
UB-VV410CI002
Phase 1 small_molecule active
Quick answer
UB-VV410 for Systemic Lupus Erythematosus is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Systemic Lupus Erythematosus
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active